Invuity Debuts PhotonBlade Dynamic Precision Illuminator With Enhanced Energy

Invuity Inc., an advanced surgical illumination company focused on minimal access surgery, recently debuted the PhotonBlade, a precision illuminator with enhanced energy delivery.
 
PhotonBlade represents an entirely new category of Intelligent Photonics, delivering directed, thermally cool illumination at the precise point of surgical treatment. Further, PhotonBlade’s energy platform consists of a proprietary shielded blade for precise cutting and coagulation of tissue, with minimal collateral effect. This sophisticated illumination technology further allows for unique use in a fluid filled environment and does not require a proprietary generator, thereby leveraging widely available operating room equipment and avoiding an institutional capital investment.
 
“We are very proud and excited with the introduction of PhotonBlade,” said Philip Sawyer, president and CEO of Invuity. “We collaborated with some of the top surgeons in the country on its design, which was created for more visualization and precision of the surgical field. This continues our strategic intention to create entirely new categories of intelligent photonics. The advanced illumination coupled with state-of-the-art energy delivery positions us solidly in an initially estimated $300 million available market for this technology. This demonstrates Invuity’s commitment to improving surgical treatment options and positively impacting patient lives.”
 
Dr. Rache Simmons, chief of Breast Surgery at New York Presbyterian Weill Cornell Medical Center (New York, N.Y.) added, “The high-quality, point-of-treatment illumination of PhotonBlade coupled with precise energy delivery provides me with the optimal tool I need to perform oncologically effective procedures through small, remote incisions. Specifically, the intracavity illumination enables me to precisely tunnel deep within a breast cavity to remove some or all of the breast tissue from an incision that can be hidden. Ultimately, this contributes to improved survivorship for my patients, which after removing the cancer, is my number one priority.”
 
Invuity develops and markets advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company’s proprietary Intelligent Photonics technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company uses comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology, and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, Calif.